BROOKLYN IMMUNOTHERAPEUTICSCS INC

BROOKLYN IMMUNOTHERAPEUTICSCS INC Share · US1140821000 · BTX (XASE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BROOKLYN IMMUNOTHERAPEUTICSCS INC
No Price
01.05.2026 20:00
Current Prices from BROOKLYN IMMUNOTHERAPEUTICSCS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
BTX
USD
01.05.2026 20:00
8,05 USD
0,11 USD
+1,39 %
IEXG: IEX
IEX
BTX
USD
01.05.2026 19:59
8,05 USD
0,11 USD
+1,39 %
XNAS: NASDAQ
NASDAQ
BTX
USD
01.05.2026 19:59
8,06 USD
0,12 USD
+1,51 %
Share Float & Liquidity
Free Float 1,44 %
Shares Float 1,68 M
Shares Outstanding 116,71 M
Company Profile for BROOKLYN IMMUNOTHERAPEUTICSCS INC Share
BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.

Company Data

Name BROOKLYN IMMUNOTHERAPEUTICSCS INC
Company BlackRock Technology and Private Equity Term Trust
Symbol BTX
Website https://www.brooklynitx.com
Primary Exchange XASE AMEX
ISIN US1140821000
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John M. Perlowski
Market Capitalization 774 Mio
Country United States of America
Currency USD
Employees -
Address 10355 Science Center Drive, 92121 San Diego
IPO Date 1991-08-29
Dividends from 'BROOKLYN IMMUNOTHERAPEUTICSCS INC'
Ex-Date Dividend per Share
15.04.2026 0,05 USD
13.03.2026 0,05 USD
13.02.2026 0,05 USD
20.01.2026 0,05 USD
22.12.2025 0,05 USD
14.11.2025 0,05 USD
15.10.2025 0,05 USD
15.09.2025 0,08 USD
15.08.2025 0,08 USD
17.07.2025 0,08 USD

Stock Splits

Date Split
17.10.2022 1:20
26.03.2021 1:2
17.06.2016 2:1

ID Changes

Date From To
20.02.2025 BIGZ BTX

Ticker Symbols

Name Symbol
NASDAQ BTX
More Shares
Investors who hold BROOKLYN IMMUNOTHERAPEUTICSCS INC also have the following shares in their portfolio:
A.MW CPAP U.E. EOD
A.MW CPAP U.E. EOD ETF
AFC ENERGY PLC   LS -,001
AFC ENERGY PLC LS -,001 Share
AMGEN INC
AMGEN INC Share
APPLIED MATERIALS INC
APPLIED MATERIALS INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
INTEL CORP
INTEL CORP Share
INTUIT INC
INTUIT INC Share
MICROSOFT CORP
MICROSOFT CORP Share
MONSTER BEVERAGE CORP
MONSTER BEVERAGE CORP Share
NCS&A Co., Ltd.
NCS&A Co., Ltd. Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
ZIOPHARM ONCOLOGY INC
ZIOPHARM ONCOLOGY INC Share